Back to results
US 6,936,255 B1Granted
Vaccine composition comprising herpes simplex virus and human papilloma virus antigens
AssigneeSmithKline Beecham Biologicals s.a.
InventorMartine Anne Cecile Wettendorff
Life of this patent
Estimating the term…
Abstract
Novel combined vaccine compositions are provided, comprising a herpes simplex virus (HSV) antigen and a HPV antigen and optionally in addition one or more of the following: an EBV antigen, a hepatitis A antigen or inactivated attenuated virus, a hepatitis B viral antigen, a VZV antigen, a HCMV antigen, a Toxoplasma gondii antigen. The vaccine compositions are formulated with an adjuvant which is a preferential stimulator of TH1 cell response such as 3D-MPL and QS21.
Claims6
A composition comprising:
- (a) a herpes simplex virus gD antigen;
- and
- (b) a human papillomavirus L1 antigen
- in conjunction with an adjuvant which is a preferential stimulator of TH1 cell response.
1 more element
Dependencies are inferred from the claim text.